
WHO-cGMP (World Health Organization – current Good Manufacturing Practices) certification shows that a pharmaceutical company meets international quality standards. In India, this certification sets manufacturers apart. India is already known as the “pharmacy of the world” because it supplies around 20% of global pharmaceutical needs. A big part of this success is due to companies that follow WHO-cGMP standards.
United Biotech India Pvt. Ltd., a key player in the Indian pharmaceutical industry, also holds WHO-cGMP certification and upholds strict manufacturing practices, ensuring high-quality medicines that meet international standards.
Why WHO-cGMP Certification Matters
WHO-cGMP certified facilities follow strict rules for how medicines are made, stored, tested, and shipped. This ensures the medicines are:
- Safe to use
- Effective
- Of consistent quality
These practices also build trust worldwide, especially in regulated markets like the U.S., Europe, and the Middle East.
Main Benefits of WHO-cGMP Certification:
- Export Advantage – Companies with this certification can export medicines more easily.
- High Formulation Quality – Medicines are made under clean and controlled environments.
- Global Reputation – Builds trust among international buyers and regulatory bodies.
- Fewer Compliance Issues – Reduces chances of product recalls and bans.
Strong Infrastructure for Exports
India’s pharmaceutical exports reached $27.9 billion in FY2024, and WHO-cGMP certified companies like United Biotech India Pvt. Ltd. are major contributors. These companies:
- Export to more than 200 countries
- Offer affordable yet high-quality generic medicines
- Comply with packaging and shipping standards for global markets
WHO-cGMP certification also helps in:
- Faster customs clearance
- Access to government tenders
- Partnerships with global health agencies like WHO and UNICEF
Focus on Quality and Compliance
Indian manufacturers now follow upgraded standards under Schedule M (revised in December 2023), which match WHO-cGMP guidelines. This update encourages:
- Use of electronic records
- Modern equipment and processes
- Cleaner and safer work environments
United Biotech India Pvt. Ltd. and similar companies follow these best practices to ensure continuous quality improvement and safety.
Key Compliance Highlights:
- Certified quality systems and regular audits
- Cleanrooms and automated production lines
- In-house labs for strict testing
- Updated training for all staff
These efforts reduce the risk of medicine shortages or export bans and help Indian companies maintain a good global reputation.
Building Global Trust
India is trusted by global health organizations because of its commitment to WHO-cGMP standards. Companies that follow these rules are seen as reliable partners.
United Biotech India Pvt. Ltd., for example, focuses on maintaining strong relationships with global clients by offering:
- Consistent quality
- Competitive pricing
- Timely deliveries
Indian companies now supply:
- 50% of global vaccine demand
- Over 20% of global generic medicines
This scale is only possible because of the high trust built through certifications like WHO-cGMP.